US 8580293
Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
granted A61KA61K31/57A61K47/34
Quick answer
US patent 8580293 (Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof) held by TEVA WOMEN'S HEALTH, INC. expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA WOMEN'S HEALTH, INC.
- Grant date
- Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/57, A61K47/34, A61K47/44, A61K9/0036